Rottapharm launches high-speed bookbuilding
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
EquityEquity IPOs

Rottapharm launches high-speed bookbuilding

CCM Pharma

Italian pharmaceuticals firm Rottapharm launched bookbuilding for a €450m IPO on Wednesday, aiming to find a premium to the sector and running a shorter bookbuilding period than normal.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article